Midori Ishii

725 citations
41 papers · 518 indexed · h-index 15
Topics
CAR-T cell therapy research (8 papers)Sarcoma Diagnosis and Treatment (7 papers)Immune Cell Function and Interaction (5 papers)
Partner nations
JapanUnited StatesIndia

In The Last Decade

Midori Ishii

36 papers receiving 503 citations

Peers

Midori Ishii
Comparison fields: 5 of 79
  • Oncology 144
  • Molecular Biology 136
  • Pulmonary and Respiratory Medicine 121
  • Rheumatology 101
  • Immunology 99
Replace Takakuni Tanizawa with:
Takakuni Tanizawa Japan
Tadaaki Yokota Japan
Aylar Poyraz Türkiye
Asuka Araki Japan
Jin‐Shuen Chen Taiwan
Chuandi Zhou China
Richard C. DʼAlonzo United States
Gustavo Pérez de Nanclares Spain
Edith Oregon‐Romero Mexico
Nerea Alonso United Kingdom
Midori Ishii relative to Takakuni Tanizawa Japan Takakuni Tanizawa's profile →
Citations per field
00.5×4.7×
Takakuni Tanizawa · 1×
Citations per year

Countries citing papers authored by Midori Ishii

Since Specialization
Citations

This map shows the geographic impact of Midori Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Ishii more than expected).

Fields of papers citing papers by Midori Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Ishii. The network helps show where Midori Ishii may publish in the future.

Co-authorship network of co-authors of Midori Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Ishii. A scholar is included among the top collaborators of Midori Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Ishii. Midori Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 3
4 10
5 1
6 0
7 17
8 4
9 29
10 3
11 21
12 16
13 7
14
A case of secondary chondrosarcoma with TP53 mutation arising from fibrous dysplasia
0
15 14
16 16
17 39
18 21
19 5
20 18

About Midori Ishii

Midori Ishii is a scholar working on Gastroenterology, Rheumatology and Oncology, having authored 41 papers that have together received 518 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Sarcoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Nephrology (83 citations), Rheumatology (101 citations) and Oncology (144 citations). Midori Ishii has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Yoshiyuki Suehara, Tsuyoshi Saito, Keisuke Akaike, Kazuo Kaneko, Kenta Mukaihara, Tatsuya Takagi, Taketo Okubo, Daisuke Kubota, Takashi Yao and Hiromitsu Nakauchi. Their work appears in journals such as Blood, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026